Relaxes the requirements for prescribing certain controlled substances as part of gender-affirming health care services. Expands the protections established under Act 2, SLH 2023, to include gender-affirming health care services. Clarifies jurisdiction under the Uniform Child-Custody Jurisdiction and Enforcement Act for cases involving children who obtain gender-affirming health care services. Effective 7/1/3000. (HD2)

Statutes affected:
HB2079: 451J-11, 451J-12, 453-8, 453-8.6, 453D-12, 453D-13, 457-12, 457-12.5, 461-21.5, 465-13, 583A-102, 583A-201, 583A-204, 583A-207, 583A-208, 836-2
HB2079 HD2: 451J-11, 451J-12, 453-8, 453-8.6, 453D-12, 453D-13, 457-12, 457-12.5, 461-21.5, 465-13, 583A-102, 583A-201, 583A-204, 583A-207, 583A-208, 636C-9, 836-2
HB2079 HD1: 451J-11, 451J-12, 453-8, 453-8.6, 453D-12, 453D-13, 457-12, 457-12.5, 461-21.5, 465-13, 583A-102, 583A-201, 583A-204, 583A-207, 583A-208, 636C-9, 836-2
Latest: 451J-11, 451J-12, 453-8, 453-8.6, 453D-12, 453D-13, 457-12, 457-12.5, 461-21.5, 465-13, 583A-102, 583A-201, 583A-204, 583A-207, 583A-208, 836-2